Radiotherapy Market Set To Be Worth of 7,544.8 Million USD by 2020

The image-guided radiotherapy (IGRT) market is expected to dominate the external beam radiotherapy market by 2020.

Persone Rohan Unit, Other
Luoghi Giappone, America del Nord, Canada, India, Pune, Stati Uniti d'America, Maharashtra, Wé
Organizzazioni Mevion Medical Systems Inc., IsoRay Medical Inc., C.R. Bard Inc., Varian Medical Systems Inc., Radiotherapy Market, Unione Socialista Indipendente, Mitsubishi
Argomenti commercio, internet, economia, impresa

09/feb/2016 09.47.12 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The report "Radiotherapy Market by Technology (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer)) - Global Forecasts to 2020", The radiotherapy market is expected to reach USD 7,544.8 Million by 2020 from USD 5,585.0 Million in 2015, at a CAGR of 6.2% between 2015 and 2020.
 
Browse 91 market tables and 48 figures spread through 177 pages and in-depth TOC on "Radiotherapy Market"
http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Early buyers will receive 10% customization on this report.
 
Radiotherapy refers to the therapeutic procedures using high energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths within our body system and repair different physiological abnormalities. A strong trend of increasing incidence of cancer cases across the globe majorly drives the growth of the radiotherapy market. Other growth factors include technological advancements in radiotherapy products, increasing symposiums driving investments in radiotherapy, rise in number of geriatric population and growing adoption of radiotherapy devices and procedures.
 
Get PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=567
 
The technology segment of radiotherapy will be important revenue pockets during the forecast period (2015–2020). By technology, the market is divided into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. The image-guided radiotherapy (IGRT) market is expected to dominate the external beam radiotherapy market by 2020. Development of advanced IGRT products, growing adoption of IGRT procedures, and growth in the number of research activities focusing on the development of advanced products are the major factors driving the growth of the IGRT technology market.
 
North America is expected to account for the largest share of the global radiotherapy market in 2015. However, the Asia-Pacific market is expected to grow at the highest rate during the forecast period from 2015 to 2020 due to increasing cases of new cancer cases and rapidly growing aging population in this region. Aging is associated with risk of developing cancer. Hence, growing aging population leads to increase in the number of new cancer cases.
 
Get Sample Copy of This Report: http://www.marketsandmarkets.com/requestsample.asp?id=567
 
As of September 2013, Japan had around 31.86 million people over 65 years of age, an increase of ~1.12 million as compared to the previous year (Source: The Ministry of Internal Affairs and Communications, Japan). It is expected that the cancer cases in Japan will rise at a high rate in the coming years owing to this increasing aging population. According to GLOBOCAN 2012, of the total 0.7 million new cancer cases in Japan in 2012, ~73% were aged 65 years and above. The growing aging population and increasing incidence of cancer in Asia-Pacific region is expected to create a significant demand for radiotherapy procedures in this region.
 
Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Nordion, Inc. (Canada), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the global radiotherapy market.
 
About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
 
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
 
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
 
Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
Get your own FREE website, FREE domain & FREE mobile app with Company email.  
Know More >
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl